Confidential mandate
Chief Strategy Officer — Industry-Solutions Business
Planned Replacement
CSO - Strategy mandate in San Francisco, USA · Artificial Intelligence
Refocus a San Francisco industry-solutions portfolio on repeatable AI products where domain access, workflow adoption and defensible economics justify continued research investment.
The mandate
An industry-solutions business has assembled promising AI work across several sectors, but its portfolio mixes repeatable products, strategic experiments and labour-intensive customer projects. Research enthusiasm and individual sponsor relationships have kept too many initiatives alive. The board wants a CSO who can make research-to-product choices without flattening valuable domain difference.
Approximately 150 employees and material partners work across sector strategy, research, product, commercial, partnerships, finance and customer delivery from San Francisco. The hybrid CSO owns enterprise strategy, portfolio allocation, market intelligence, strategic partnerships, investment cases and board decision architecture, reporting to the Group Chief Executive or designated executive committee sponsor.
The portfolio review will start with the customer decision each solution changes. Users, workflow, baseline, data access, integration and consequence should be specific. A technically impressive model serving no budgeted or adopted decision will remain research, not a product business in disguise.
Industry attractiveness must combine market and execution access. Regulation, data rights, buying cycles, incumbent systems, liability and domain talent can matter more than headline spending. The CSO will assess whether the organisation has a durable route to evidence and customers rather than assume model capability transfers equally across sectors.
Repeatability will be tested at the component level. Common model services, workflow modules, controls or evaluation assets may support multiple solutions even when end products differ. The strategy should identify what genuinely scales and which domain work remains local. Reuse claimed only in presentation architecture will not underpin investment.
Research options need bounded commitments. Early work should state hypothesis, learning milestone, required access and stop condition. The CSO will protect exploration from premature revenue targets while preventing open-ended subsidy. Sunk effort and executive sponsorship are not reasons to pass the next gate.
Product cases will include adoption. Workflow change, user trust, training, integration and operating support must be costed alongside model development. A pilot that shows accuracy but never changes a customer process is evidence about technical feasibility, not commercial readiness.
The vertical portfolio must account for concentration. One anchor customer can accelerate learning yet distort roadmap and economics. Strategic projects need rights to reusable insight, clear bespoke boundaries and an exit from dedicated resourcing. Customer-funded development does not automatically create a scalable asset.
Partnerships may supply domain access, distribution or regulated capability. The CSO will evaluate exclusivity, data control, brand, dependency and value sharing. A prestigious partner whose approvals or incentives prevent broader use can narrow strategic option rather than expand it.
Capital allocation will compare products and research on risk-adjusted evidence. Cash, technical capacity, time to learning and downside should be visible. Portfolio reviews will state what stops when a new priority starts. Strategy cannot solve scarcity by labelling every initiative strategic.
Competitive intelligence will examine workflow alternatives, not only AI vendors. Customers may improve through rules, process change or incumbent software. The solution must earn adoption against those options. The CSO will challenge proposals whose value depends on customers accepting avoidable technology complexity.
Board choices should preserve disagreement. Product, research and commercial leaders will provide evidence and confidence ranges. The CSO will make assumptions, dependencies and irreversible steps explicit rather than merge forecasts into false consensus. Decisions will carry follow-up indicators capable of changing course.
The successor must retain institutional memory without inheriting portfolio bias. The outgoing CSO's partner context, rejected alternatives and conditional commitments require structured handover. Strategy leaders will own sectors and methods beneath the role, creating credible succession and sharper accountability.
What you will own
- Industry and workflow portfolio strategy.
- Research option and product-investment gates.
- Repeatability, adoption and solution economics.
- Sector access, concentration and competitive intelligence.
- Strategic partnership choices and dependencies.
- Capital and technical-capacity allocation.
- Board decisions and portfolio indicators.
- Strategy transition, team and succession.
The first 12 months
Within 45 days, secure incumbent handover, classify every initiative as research option, repeatable product or customer-specific delivery and surface unsupported commitments. Present a portfolio fact base to the board.
By month six, close or redesign low-evidence initiatives, establish workflow and adoption gates and approve priority sector theses with explicit access and partnership requirements. Reallocate technical capacity to the strongest cases.
At twelve months, concentrate 80% of growth investment in no more than four supported solution theses, reduce unfunded bespoke work by 40% and move three research options into repeatable customer use. Every retained initiative must meet its evidence gate, with US$120 million of capital or capacity released from weaker paths.
What the sponsor will examine
- Customer decisions defined before technology choices.
- Sector attractiveness adjusted for actual access.
- Reuse demonstrated in working assets.
- Adoption and integration inside product economics.
- Portfolio additions accompanied by explicit displacement.
- Indicators able to reverse a prior board choice.
The person
You bring 22–28 years in corporate strategy, AI products, industry software or technology investment, including CSO or portfolio authority. Your record includes research allocation, vertical market choice, strategic partnerships, product economics and board decisions across several industries.
Candidates must explain a celebrated AI initiative they stopped for weak workflow adoption and a research option they protected from premature commercialisation. The role is hybrid in San Francisco with significant board, customer and partner presence.
Compensation and terms
Base compensation is US$320,000–420,000 plus annual incentive linked to portfolio concentration, evidence quality, scalable adoption, released capacity and strategy succession. The permanent hybrid San Francisco CSO reports to the Group Chief Executive or designated executive committee sponsor. Planned replacement provides for structured board and partner handover.
Confidentiality
The business, sector theses, research, customers, partnerships, investment cases and succession context remain confidential. Additional information follows conflicts, relevance and signed confidentiality. Applicants must not approach AI firms, industry partners, customers or board members to establish the identity of the principal.
More seats like this one
This mandate is confidential. The client is named only under a mutual NDA, and your own record is never listed, sold or shown to a company under your name until you release it for this specific mandate.